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NEONATAL ABSTINENCE SYNDROME NONPHARMACOLOGICAL 








 Neonatal abstinence syndrome has increased significantly in the United States 
over the past few decades due to the increase of maternal substance abuse. The overall 
goal of caring for these infants is effective management of the withdrawal symptoms, 
including both pharmacological and nonpharmacological interventions. However, 
nonpharmacological interventions have been shown to improve infant outcomes and 
reduce length of hospitalization. This project sought to increase healthcare professionals’ 
knowledge and confidence regarding neonatal abstinence syndrome and the utilization of 
nonpharmacological interventions when caring for infants diagnosed with neonatal 
abstinence syndrome through the provision of an educational presentation. This study 
utilized a one-group pretest-posttest design with healthcare professionals caring for 
newborns in a hospital setting. Healthcare professionals were recruited via convenience 
and snowball sampling through social media platforms. Participants’ knowledge and 
confidence were measured before, after, and six-weeks following an educational 
presentation. According to the findings, the educational presentation improved healthcare 
professionals’ knowledge and confidence regarding neonatal abstinence syndrome and 
the utilization of nonpharmacological interventions when caring for an infant diagnosed 
with neonatal abstinence syndrome. These findings determine that education can be 
beneficial for increasing healthcare professionals’ knowledge and confidence regarding 
neonatal abstinence syndrome and the utilization of nonpharmacological interventions. 
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 Over the past few decades the United States has been in the midst of an opioid 
epidemic. This epidemic has not discriminated and has significantly affected pregnant 
women, which has consequently caused an increase in infants being exposed to drugs in-
utero. This epidemic has resulted in infants being born and going through withdrawal 
shortly after birth. This withdrawal is known as neonatal abstinence syndrome. “Neonatal 
Abstinence Syndrome (NAS) is the result of sudden discontinuation of fetal exposure to 
substances [legal or illegal] that were used or abused by the mother during her 
pregnancy” (Kocherlakota, 2014, p. e547). This post-withdrawal syndrome produces both 
behavioral and physiological signs and symptoms in the neonate, resulting in longer 
hospital stays and increased cost of care.  
 Infants born suffering from NAS are typically admitted to a hospital’s Neonatal 
Intensive Care Unit for an extended period of time to reduce withdraw symptoms and 
stabilize the infant before discharge home. Treatment of NAS can include both 
pharmacological interventions, most commonly morphine (Kocherlakota, 2014, p. e554), 
and nonpharmacological interventions. However, “because of the complex nature of 
withdrawal […] there are currently no uniformly accepted pharmacological interventions 
or standardized regimens for the management of NAS” (Kocherlakota, 2014, p. e554). 
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Nonpharmacological interventions are less controversial, less expensive, and have the 
potential to reduce the average length of stay (Grossman, Berkwitt, Osborn, Xu, 
Esserman, Shapiro, & Bizzarro, 2017, p.e4).  
Significance of Clinical Problem 
 As the United States faces an increase in the use of, and dependence on, 
controlled substances, especially opioids, the risk of infants being born with neonatal 
abstinence syndrome also increases. According to Chiang, Okoroh, Kasehagen, Garcia-
Saavedra, and Ko (2019), the increase in NAS is attributed to the increase in maternal 
opioid use, including misuse of prescribed opioids, use of illicit opioids such as heroin, 
and the use of medication to help assist in the treatment of opioid use disorders such as 
methadone.  In 2000, opioid use in pregnant women was 1.1 per 1000 hospital deliveries 
and has since increased to 6.5 per 1000 in 2014 (Chiang et al., 2019, p. 1193). “In the 
past 10 years, rates of newborns diagnosed with NAS have risen fivefold in the United 
States, from 1.5 per 1000 hospital births in 2004 to 8.0 in 2014” (Chiang, et al., 2019, p 
1193) As the maternal use of opioids and illicit drugs continues to rise, the incidence of 
NAS will also continue to rise, leading to more infant hospitalizations in the Neonatal 
Intensive Care Unit, longer hospital stays for infants, and an increase in the cost of 
healthcare for these infants.  
 According to Kocherlakota (2014), infants that are born with exposure to opioids 
while in-utero and are consequently diagnosed with neonatal abstinence syndrome can 
exhibit an adverse and wide variety of symptoms affecting the autonomic nervous 
system, central nervous system, respiratory system, and the gastrointestinal system. NAS 
can present with many different signs and symptoms ranging from mild to severe. The 
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withdrawal symptoms that may manifest include, but are not limited to, “fever, sweating, 
tachypnea, tremors, poor eating, weight loss, seizures, crying […]” (Allen, Prunty, 
Babcock, Attarabeen, & Patel, 2018, p. 1750), excessive sneezing, excessive yawning, 
excessive sucking, vomiting, diarrhea, and excoriations throughout the body 
(Kocherlakota, 2014, p. e551- e552). Each symptom can manifest in varying degrees and 
extremes, or may not manifest at all. Depending on the severity of these symptoms, many 
infants require a prolonged and costly hospitalization in NICUs.  
 The average length of stay for infants suffering from NAS was “16 days and those 
requiring pharmacologic treatment had a mean length of stay of 23 days” (Patrick, Davis, 
Lehman, Cooper, 2015, p. 5) resulting in high healthcare costs.  According to Corr and 
Hollenbeak (2017), the significant increase in NAS admissions has resulted in a large 
increase in annual healthcare costs. The annual healthcare related costs in 2003 for 
infants with NAS were $61 million with a total of 67,869 hospital days. In 2012, the 
annual costs had increased to $316 million with a total of 291,168 hospital days (Corr & 
Hollenbeak, 2017, p. 1593). In comparison to an infant not affected by NAS, hospital 
stays were three and a half times longer and cost three times more in infants suffering 
from NAS. 
Significance to Nursing 
 Nurses working in the Neonatal Intensive Care Units (NICU) provide direct care 
to infants diagnosed with NAS. Patient assessments, administering medication treatment 
regimens, educating family, and providing support to both infants and the family are all 
tasks that nurses are at the forefront of providing. While caring for these infants does take 
a collaborative effort between neonatologists, neonatal nurse practitioners, occupational 
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therapists, physical therapists, speech therapists, social workers, and caregivers, nursing 
plays a pivotal role. Nurses provide not only bedside care including comforting, feeding, 
diaper changes, swaddling, and assessments but also care that extends past the bedside, 
including parent support and education. Unfortunately, care extending beyond the 
bedside also often includes legal matters that exist within the infant’s case.  
 Neonatal abstinence syndrome symptoms and their severity depend on multiple 
factors, including: type of drug or drugs used, amount and frequency of drug/drugs used, 
gestation of infant at birth, and the trimester in which the drugs were used (Kocherlakota, 
2014, p. e551). However, “because NAS is a syndrome, there is a wide range of signs 
that a neonate could display, and clinical assessment of these signs is not standardized 
across practices” (Chiang, et al, 2019, p. 1193). 
 The overall goal of caring for these infants is effective management of the 
withdrawal symptoms. Management can include both pharmacological and 
nonpharmacological treatment methods. According to Allen et al. (2018), 
“nonpharmacological therapy may reduce the length of hospitalization, minimizing 
medication therapy requirements and reduce risk associated with medication therapy in 
infants” (p. 1750).  
 Traditionally, neonates suffering from withdrawal are scored based on the 
presence and severity of withdrawal symptoms. These symptoms are scored based on a 
specific scoring tool, such as Finnegan Neonatal Abstinence Scoring Tool (FNAST), 
Lipsitz Neonatal Drug Withdrawal Scoring System, and Neonatal Withdrawal Inventory 
scoring system (NWI). The Finnegan scoring tool uses a 21-point item measuring 
symptoms, can be utilized for both opioid and non-opioid withdrawal assessments and 
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remains the most common tool utilized (Kocherlakota, 2014, p. e553). When utilizing the 
Finnegan Scoring Tool, symptoms should be scored every three to four hours while the 
infant is awake. Scoring should also take place after the infant has eaten, before an 
assessment, during an assessment, and directly following an assessment (Kocherlakota, 
2014, p. e553). Treatment protocols may differ from institution to institution, but the 
higher the score leads to a higher incidence in pharmacological management rather than 
nonpharmacological interventions. However, the first line of treatment should always be 
nonpharmacological interventions. Examples of nonpharmacological interventions 
include comfort measures, tight swaddling with lightweight blankets, providing quiet 
environments, low lighting environments, massage, encouraging frequent uninterrupted 
rest periods, rocking, use of a swing, pacifier use, frequent feedings, caregiver rooming 
in, and if appropriate breastfeeding (Allen et al., 2018, p.1750; Kocherlakota, 2014, p. 
e553). As a healthcare professional caring for these infants, the role is to provide these 
nonpharmacological interventions to help the infant improve their symptoms in a more 
comfortable environment.  
 Recently, studies began identifying the importance of nonpharmacological 
interventions and their effects on infant outcomes and length of stay. “The first and 
foremost goal of NAS care should be to establish an organized protocol with a 
standardized scoring tool for NAS, as symptoms can be subjective. Nonpharmacological 
therapy should be included in the protocol” (Allen, et al., 2018, p. 1750). 
Nonpharmacological interventions are less controversial, less expensive, and can lead to 
earlier discharges from the hospital. According to Kocherlakota (2014), 
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“Nonpharmacological therapy is the first line in all cases [and] can be attempted in all 
infants before pharmacological therapy” (p. e553). 
Specific Purpose 
 The purpose of this Doctor of Nursing Practice (DNP) Scholarly Project was to 
educate healthcare professionals caring for newborns diagnosed with Neonatal 
Abstinence Syndrome on nonpharmacological interventions. Pharmacological 
interventions can pose risks to the infant, while nonpharmacological interventions do not 
possess the same potential adverse effects. The introduction of nonpharmacological 
intervention education can aid in the standardization of treatment interventions for NAS 
infants. This education for healthcare professionals can also be utilized to help educate 
parents/family caregivers about the signs and symptoms of NAS and the appropriate 
interventions to help provide comfort to the infant before initiating pharmacological 
management.  
Theoretical Framework 
 The theoretical framework chosen for this project is Orlando's Nursing Process 
Discipline Theory (Figure 1). This theory focuses on a patient’s needs. The healthcare 
professional’s role in this theory is to help discover and meet the immediate needs of the 
patient, which would result in a positive outcome (Petiprin, 2016, para. 3). Healthcare 
professionals must use their own intuition and critical thinking skills in order to discover 
and meet the needs of the patients. This theory "focuses on the interaction between the 
[healthcare professional] and patient, perception validation, and the use of the nursing 
process to produce positive outcomes or patient improvement" (Petiprin, 2016, para. 9). 
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 The major assumptions from Orlando’s Nursing Process Discipline Theory 
(Petiprin, 2016, para. 8) that apply to this project include: 
• When patients are unable to cope with their needs on their own, they 
become distressed by feelings of helplessness. 
• In its professional character, nursing adds to the distress of the patient. 
• Patients are unique and individual in how they respond. 
• Nursing offers mothering and nursing analogous to an adult who 
mothers and nurtures a child. 
• The practice of nursing deals with people, environment, and health.  
• Patients need help communicating their needs; they are uncomfortable 
and ambivalent about their dependency needs. 
• The [healthcare professional-patient] situation is dynamic; actions and 
reactions are influenced by both the nurse and the patient.  
• The patient is unable to state the nature and meaning of his or her 
distress without the help of the [healthcare professional], or without 
him or her first having established a helpful relationship with the 
patient. 
• Any observation shared and observed with the patient is immediately 
helpful in ascertaining and meeting his or her need, or finding out that 
he or she is not in need at that time.  
• [Healthcare professionals] are concerned with the needs the patient is 
unable to meet on his or her own. 
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Figure 1  
Theoretical Framework Model 
 
Note: Adapted from Orlando’s Nursing Process Discipline Theory 
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Practice Questions  
 The following are the practice questions that the DNP Scholarly Project will 
address.  
1. Prior to an educational offering, how frequently are healthcare 
professionals caring for newborns in the hospital setting completing a 
Finnegan Score on newborns born to women who tested positive for 
substances known to cause NAS? 
2. Prior to an educational offering on the nonpharmacological management 
of NAS, which interventions are healthcare professionals caring for 
newborns in the hospital setting implementing? 
3. Will implementation of nonpharmacological intervention education 
improve the knowledge of healthcare professionals caring for infants 
diagnosed with NAS in the hospital setting? 
4. Will implementation of nonpharmacological intervention education 
improve the confidence of healthcare professionals caring for infants 
diagnosed with NAS in the hospital setting? 
Definition of Key Terms 
 Key terms used throughout the DNP project are listed and defined below.  
• Caregivers - The persons who will be caring for the infant diagnosed with 
NAS outside of the hospital setting.  
• Finnegan Neonatal Abstinence Syndrome Scoring Tool (FNAST) - A 
scoring tool used to quantify the symptoms of Neonatal Abstinence 
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Syndrome. This tool helps to direct care towards nonpharmacological or 
pharmacological interventions.  
• Healthcare Professionals - The persons who care for an infant diagnosed 
with NAS while admitted to an inpatient care facility, including certified 
nurse aids, registered nurses, lactation consultants, social workers, 
physician’s assistants, nurse practitioners, and physicians. 
• Neonatal Abstinence Syndrome - The result of sudden discontinuation of 
fetal exposure to substances, legal or illegal, that were used or abused by 
the mother during her pregnancy (Kocherlakota, 2014, p. e547). 
• Neonatal Intensive Care Unit (NICU) - A unit within a hospital that 
specializes in the care of critically ill infants.  
• Nonpharmacological Intervention Education - An educational presentation 
utilized by healthcare professionals and caregivers to help identify 



















 Neonatal abstinence syndrome is a complex condition that affects infants who 
were exposed to legal and illegal substances in utero. The exposure to these substances 
results in withdrawal from the substance or substances. Potential symptoms that may be 
experienced include excessive sweating, fevers, high-pitched cry, poor feedings, tremors, 
excessive sucking, excessive sneezing, excessive yawning, and excoriations throughout 
the body.  
  Neonatal abstinence syndrome is an unfortunate consequence of the increasing 
opioid epidemic within the United States. The goal of this project is to offer alternative 
and effective treatment strategies for neonatal abstinence syndrome—through the 
introduction of education addressing nonpharmacological interventions that can help 
comfort the infant and manage symptoms that manifest during the withdrawal period. 
This education will be aimed to help aid healthcare professionals and caregivers in their 













Integrated Review of the Literature 
 
 
As stated in the introductory chapter, the incidence of neonatal abstinence 
syndrome has increased drastically in the past decade, which is attributed to the increased 
incidence of maternal substance abuse (Chiang et al., 2019, p. 1193). Recent research has 
guided changes in clinical practice guidelines, moving from treatment of NAS with 
pharmacological measures to first line therapy being nonpharmacological interventions. 
Research has shown improved patient outcomes, reduced length of stay, and improved 
bonding with caregivers with the implementation of nonpharmacological interventions 
(MacVicar & Kelly, 2019).  The increased incidence of NAS should provide the 
motivation for healthcare providers to improve treatment interventions.  
A review of the literature related to NAS was conducted using CINHAL PLUS 
with full text and UpToDate electronic databases. Search terms that were utilized 
included “neonatal abstinence syndrome,” “neonatal abstinence syndrome and 
management,” “neonatal abstinence syndrome and nonpharmacological interventions,” 
“neonatal abstinence syndrome and length of stay,” “neonatal abstinence syndrome and 
cost of care,” “neonatal abstinence syndrome treatment,” and “neonatal abstinence 
syndrome and incidence.” Utilizing these terms and phrases, the articles were reviewed 
for relevance, and selected accordingly. Publication dates utilized for this literature 
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review ranged from 2010 to 2020. Ancestral research was also performed by utilizing the 
reference lists of the selected articles. This ancestral research allowed for the 
identification of new sources of information. The review of literature gave insight on 
neonatal abstinence syndrome, nonpharmacological interventions for neonatal abstinence 
syndrome, the link between nonpharmacological interventions and infant outcomes, the 
link between nonpharmacological interventions and infant length of stay, and financial 
burdens due to neonatal abstinence syndrome. 
The purpose of this literature review was to gain knowledge on neonatal 
abstinence syndrome, symptoms scoring tools, management of NAS including 
pharmacological and nonpharmacological interventions, and healthcare expenditures due 
to NAS. The knowledge obtained in the literature review will be presented to healthcare 
professionals caring for newborns in a hospital setting through an educational offering as 
part of the scholarly project. By increasing the nonpharmacological intervention 
knowledge of healthcare professionals caring for newborns in a hospital setting, 
newborns suffering from neonatal abstinence syndrome will receive higher and improved 
quality of care while hospitalized.  
Neonatal Abstinence Syndrome 
 “Neonatal Abstinence Syndrome (NAS) is the result of sudden discontinuation of 
fetal exposure to substances [legal or illegal] that were used or abused by the mother 
during her pregnancy” (Kocherlakota, 2014, p. e547). This post-withdrawal syndrome 
produces both behavioral and physiological signs and symptoms in the neonate, resulting 
in longer hospital stays and increased cost of care. The subsequent sections of this 
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chapter will review NAS incidence, the impact of NAS signs and symptoms, scoring 
tools, management, cost of care, and length of stay in relation to an NAS diagnosis.  
 Incidence. As previously stated, substance abuse disorders among pregnant 
women have increased dramatically in the past decade, consequently resulting in 
increased incidence of neonatal abstinence syndrome. Between the years 2004 and 2010, 
the incidence of newborns diagnosed with NAS increased fivefold, which has inevitably 
increased the number of newborns requiring longer hospitalization and specialized care 
(Chiang et al., 2019, p. 1193). The diagnosis of NAS is a result of the abrupt 
discontinuation of substances used by a mother during pregnancy (Kocherlakota, 2014, p. 
e548) and has spread across socioeconomic statuses (Washington & Wilson, 2019, p. 48).  
 Impact and Symptoms. Many different substances, legal or illegal, can result in 
NAS. These substances include prescription opioids, heroin, cocaine, methamphetamines, 
methadone, buprenorphine, antidepressants, anxiolytics, synthetic narcotics, 
hallucinogens, and kratom.  (Artigas, 2014, p. 510; Kocherlakota, 2014, p. e549; & 
Jansson, 2020, p. 2). Infants exposed to these substances while in-utero have the potential 
of NAS after birth, which can lead to a variety of problems. These problems include 
gastrointestinal, metabolic, and central nervous system effects (Allen et al., 2018, p. 
1750).  
 According to the literature, symptoms of NAS can vary vastly and are dependent 
upon multiple factors such as last maternal substance use, substance type, amount, half-
life, and singular or polysubstance exposure (Cook & Fantasia, 2019, p. 359; 
Kocherlakota, 2014, p. e551). NAS can present with many different signs and symptoms 
ranging from mild to severe. Presentation of signs and symptoms can include tremors, 
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irritability, excessive, high-pitched and inconsolable crying, diarrhea, jitteriness, 
agitation, short or irregular sleep patterns, hypertonia, myoclonic jerks, seizures, 
increased heart rate and respiratory rate, temperature instability, sweating, frequent 
sneezing, frequent yawning mottling, nasal flaring, nasal stuffiness, poor feedings, 
regurgitation, excoriations, hyperphagia, excessive sucking, and poor weight gain 
(Artigas, 2014, p. 511; Cook & Fantasia, 2019, p. 358; Kocherlakota, 2014, p. e551- 
e552).  
 Symptom Scoring Tools. Assessments and the use of scoring tools allows for 
providers to initiate appropriate interventions when treating NAS. The most frequently 
utilized scoring tool is the Finnegan Neonatal Abstinence Scoring Tool (FNAST); 
however, other scoring tools include Lipsitz Neonatal Drug Withdrawal Scoring System, 
and the Neonatal Withdrawal Inventory (NWI) scoring system (Artigas, 2014). NAS 
scoring tools help healthcare professionals and caregivers to quantify the severity of NAS 
symptoms and therefore guide treatment. Additionally, according to Cook and Fantasia 
(2019), hospitals have started to adopt a new assessment tool that focuses less on 
numerical scoring and more on the behavior of the neonate. This scoring method is 
referred to as the Eat, Sleep, Console (ESC) method and focuses primarily on 
nonpharmacological interventions. This project utilized the Finnegan Scoring Tool. 
 The Finnegan Scoring Tool was developed by Loretta Finnegan in 1975 as both a 
clinical and investigative tool (Zimmerman, Nötzli, Rentsch, & Bucher, 2010). The tool 
assesses “central nervous system hyperirritability, gastrointestinal dysfunction, 
respiratory distress and vague autonomic signs in a semi quantitative way” (Zimmerman-
Baer et al., 2010, p. 524). The tool includes a list of 21 different symptoms that an infant 
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may display while experiencing NAS. The 21 symptoms are given a score based on 
manifestation and severity to quantify severity. Once an infant “scores greater than or 
equal to 12 at two consecutive assessments, or greater than or equal to a score of 8 at 
three consecutive assessments, pharmacological intervention is initiated” (Cook & 
Fantasia, 2019). Appropriate education and training for healthcare providers and 
caregivers is essential for providing consistency while performing NAS assessments and 
assigning scores. 
Management 
 Management of NAS is an important factor in overall infant outcomes and can 
include both pharmacological and nonpharmacological interventions. Treatment 
modalities should begin with nonpharmacological interventions followed by 
pharmacological interventions when withdrawal symptoms are unable to be reduced by 
nonpharmacological interventions.  
Pharmacologic. According to Kocherlakota (2014), there is no uniformly 
accepted standardized protocol or regimen for the management of NAS with 
pharmacological interventions. However, literature is consistent in stating that morphine 
is the most commonly utilized medication (Cook & Fantasia, 2019, p. 361; Jansson, 
2020, p. 14; Kocherlakota, 2014, p. e554). Other medications that can be utilized include 
methadone, buprenorphine, clonidine, and phenobarbital (Cook & Fantasia, 2019; 
Kocherlakota, 2014). Though medication modalities can help to reduce withdrawal 
symptom severity, the use of pharmacological therapy ultimately increases average 
length of stay and associated healthcare costs (Grossman et al., 2017). With proper 
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education and training, the utilization of these medications can be avoided with the use of 
intensive nonpharmacological interventions.  
Nonpharmacological. Nonpharmacological interventions should always be first 
line therapy for management of NAS and require “thorough evaluation of the newborn’s 
behaviors and responses to interactions and the environment to determine the need for 
specific soothing techniques” (Artigas, 2014, p. 511). Nonpharmacological interventions 
have been shown to reduce the length of hospitalizations, minimize medication therapy, 
improve infant outcomes, and ultimately reduce healthcare associated costs (Allen et al., 
2018; Kocherlakota, 2014). Examples of nonpharmacological supportive care include 
gentle handling, on demand feedings, swaddling, dim light, low noise, frequent feedings, 
utilizing high calorie formulas, holding, cuddling, manual rocking, aromatherapy, 
massage therapy, skin-to-skin contact, pacifier use to promote “self-soothing”, caregiver 
rooming-in, breastfeeding, and increasing parent/caregiver infant care (Allen et al., 2018; 
Artigas, 2014; Cook & Fantasia, 2019; Jansson, 2020; Kocherlakota, 2014; MacVicar & 
Kelly, 2019). These interventions should be utilized by parents, caregivers, volunteers, 
and healthcare professionals to improve quality of care for infants diagnosed with NAS. 
If withdrawal symptoms are not well controlled with current interventions, the caregiving 
team must re-evaluate and adjust interventions accordingly.  
Cost and Length of Stay. A quality improvement initiative developed and 
implemented by Grossman et al. (2017) and a multidisciplinary team showed a reduced 
average length of stay for infants diagnosed with NAS by implementing intensive 
nonpharmacological interventions. The multidisciplinary team initiated four main 
nonpharmacological interventions. These interventions included placing infants in low 
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stimulation environments with dim lighting and reduced noise, engaging parents in the 
care of the newborns by encouraging rooming in and feeding on demand, training staff to 
view nonpharmacological interventions as equivalent to pharmacological interventions, 
and encouraged breastfeeding of all infants unless contraindicated due to illicit drug use 
(Grossman et. al., 2017). Conclusions of the quality improvement initiative showed that 
by modifying how infants with NAS are managed the average length of stay is reduced 
from an average of 23 days to an average of six days and overall quality of care was 
improved substantially.  
Similarly, in a mixed study review of 14 studies on nonpharmacological 
interventions for infants diagnosed with NAS, MacVicar and Kelly (2019) found that the 
implementation of nonpharmacological interventions led to a reduction in length of 
hospitalization and a decreased need for pharmacological interventions. Each study 
showed a decrease in length of stay and a decreased need for pharmacologic therapy 
when nonpharmacological interventions were initiated early. 
Healthcare Expenditures. As the incidence of maternal substance abuse and 
NAS increase, the more hospitalizations and healthcare costs also increase. According to 
a retrospective, observational study completed by Corr and Hollenbeak (2017), between 
2003 and 2012, the number of infants born and hospitalized with a diagnosis of NAS 
increased fourfold. This fourfold increase resulted in a total of 67,869 hospital days and 
$61 million in healthcare costs in 2003 compared to 291,168 hospital days and $316 
million in healthcare costs in 2012 (Corr & Hollenbeak, 2017, p. 1590). By 2014, the 
healthcare costs of NAS had increased to $462 million (Winkleman, Villapiano, 
Kozhimannil, Davis, & Patrick, 2018, p. 1).The study conducted by Corr and Hellenbeak 
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(2017) concluded that this increase included the length of stay being 3.5 times longer for 
NAS diagnosed infants versus infants without NAS. The average cost of admission and 
hospital stay for a newborn not affected by NAS was an average of $18,518.72 compared 
to the average cost of admission and hospital stay for an infant not affected by NAS of 
$5,429.28 (Corr & Hollenbeak, 2017, p. 1593-1595). 
According to a quality improvement initiative to improve the quality of care NAS 
infants received by utilizing nonpharmacological interventions by Grossman et al. (2017), 
the average length of stay for all infants with NAS was 17 days and the average length of 
stay for infants with NAS requiring pharmacological management was 23 days.  
Grossman et al. (2017) concluded that by initiating nonpharmacological interventions in 
the treatment of NAS, the average length of stay and average cost of stay was 
significantly decreased. 
Summary 
 The review of literature revealed that though there are significant benefits of 
utilizing nonpharmacological interventions in the care of NAS, there is still a gap in 
practice protocols and guidelines. Pharmacological therapy has traditionally been known 
to help reduce the symptoms of NAS, but at what cost? The literature remained consistent 
in concluding that nonpharmacological interventions promote parent/caregiver bonding, 
improve infant outcomes, reduce length of hospitalizations, and ultimately reduce 
healthcare expenditures. The positive outcomes of nonpharmacological interventions 
included in this literature review provided significant evidence that NAS can be managed 
successfully while also reducing length of hospitalizations and reduced healthcare costs. 
Healthcare professionals providing care to infants diagnosed with NAS have a duty to 
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advocate and participate in the development of improved evidence-based guidelines and 
protocols to improve infant outcomes by utilizing nonpharmacological interventions in 















 The increasing incidence of neonatal abstinence syndrome should be of great 
concern to healthcare providers, especially for healthcare professionals caring for 
newborns that are diagnosed with NAS. Healthcare professionals caring for newborns are 
in a position to help improve infant outcomes and reduce not only length of stay but also 
reduce healthcare costs when caring for infants diagnosed with NAS by utilizing 
nonpharmacological interventions. The goal of this project was to increase healthcare 
professionals’ confidence, knowledge of, and intent of utilizing nonpharmacological 
interventions in the treatment of NAS. Through an educational presentation, healthcare 
professionals caring for newborns in a hospital setting will be better equipped and 
prepared to care for infants diagnosed with NAS, which will ultimately improve patient 
care and outcomes. This chapter details the design of the scholarly project.  
Project Design 
 This study was designed to determine if the knowledge and confidence of 
healthcare professionals caring for newborns in the hospital setting would increase after 
an educational presentation was provided. This educational presentation introduced and 
explained neonatal abstinence syndrome and nonpharmacological interventions that can 
be implemented when treating an infant with NAS. The education was provided in a 
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voice recorded PowerPoint presentation. The educational presentation included a 
pre/post-test survey, as well as a follow-up posttest survey occurring six weeks later. The 
focus of the study was to increase the utilization of nonpharmacological interventions 
when caring for infants diagnosed with NAS by increasing healthcare professionals’ 
knowledge and confidence. Nonpharmacological intervention knowledge and confidence 
levels were screened before the educational presentation, immediately after the 
educational presentation, and again six weeks post educational presentation.  
 The educational presentation was provided to healthcare professionals who care 
for newborns in a hospital setting. Prior to the educational presentation, a pre-test survey 
was provided to participants to determine their current knowledge, confidence, and 
utilization of nonpharmacological interventions while caring for infants diagnosed with 
NAS. The posttest and six-week follow-up posttest assessed if the educational 
presentation increased the healthcare professionals’ knowledge and understanding of 
NAS, confidence in providing nonpharmacological interventions, and the intent to utilize 
nonpharmacological interventions when caring for infants diagnosed with NAS. 
Setting and Participants 
 The target population included healthcare professionals who care for newborns in 
a hospital setting. The participants were able to access the educational learning program 
asynchronously at their convenience to gain knowledge of nonpharmacological 
interventions in the treatment of NAS. A convenience sampling of certified nurse aids 
(CNAs), registered nurses (RNs), lactation consultants (LCs), social workers, physician’s 
assistants (PAs), nurse practitioners (NPs), and physicians (MD or DO) was utilized. The 
convenience sample was obtained by contacting colleagues known to work as healthcare 
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professionals caring for newborns in a hospital setting and asking them to participate. 
These colleagues were also asked to share the educational presentation and survey link 
with other healthcare professionals within their personal network, resulting in a snowball 
technique. E-mail, telephone contact, personal contact, and social media were utilized to 
recruit participants. All participants who participated in the educational presentation 
received a pretest and posttest. Participants had the option to complete a six-week follow-
up posttest survey if they elected to provide their email address. Inclusion criteria 
included the participant being a healthcare professional caring for newborns in the 
hospital setting with a valid healthcare professional license, 18 years of age or older, and 
English speaking. Exclusion criteria included the participant being younger than 18 years 
of age, non-English speaking, and healthcare professionals who do not care for newborns 
in the hospital setting. 
Protection of Human Subjects 
 An Institutional Review Board (IRB) application was submitted to the Pittsburg 
State University Committee for the Protection of Human Research Subjects (CPHRS) for 
review and approval. The target population included adult subjects with a healthcare 
professional license. All surveys were answered confidentially and confidentiality was 
maintained throughout the research process. There were minimal risks associated with the 
pretest and posttest. The survey responses remained anonymous.  
 The project data was obtained through the pretest, posttest, and six-week follow-
up posttest. The educational presentation was strictly voluntary and no monetary 
compensation was provided. The data from the pretest, posttest, and six-week posttest 
was analyzed using descriptive and t-test statistics to determine if knowledge and 
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confidence in providing nonpharmacological interventions for the management of NAS 
increased after healthcare professionals caring for newborns in a hospital setting 
completed the educational presentation. The pretest, posttest, and six-week follow-up 
posttest maintained confidentiality and were provided through Qualtrics.   
Instruments 
 This study utilized three online surveys to obtain data including a pretest, posttest, 
and six-week follow-up posttest if participants chose to provide their email. Each survey 
was administered through the third-party online survey software Qualtrics. The surveys 
included a pretest prior to the educational presentation, posttest immediately following 
the educational presentation, and a six-week posttest. The surveys assessed 
demographics, knowledge, confidence, and personal thoughts on NAS management and 
interventions from the participants’ experience. The surveys included both forced choice 
and open-ended questions, as well as a comment section at the end. The data from the 
pretest, posttest, and six-week posttest was analyzed using descriptive and t-test statistics 
to determine if knowledge of nonpharmacological interventions increased, confidence in 
providing nonpharmacological interventions increased, and if nonpharmacological 
interventions were more frequently utilized. The pretest, posttest, and six-week posttest 
were reviewed by Pittsburg State University School of Nursing Faculty members to 
ensure content validity.  
Procedure 
 The timeline of the project was as follows: The proposal was sent to the proposal 
committee on October 27, 2020. A meeting via ZOOM with the proposal committee took 
place on November 10, 2020. At this proposal meeting, project content, ideas, and 
 26 
organizational structure were discussed. On December 1, 2020, Pittsburg State University 
IRB was approved. The educational presentation, pretest and posttests were then 
provided and data was collected between December 2020 and January 2021. The 
proposal defense then took place on April 5, 2021 and consisted of Pittsburg State 
University School of Nursing Faculty members as well as a member of the Pittsburg State 
University Department of Psychology and Counseling.  
  The educational offering was a web-based distant learning opportunity provided 
through the third-party software Qualtrics. The educational presentation included a 
pretest, recorded educational presentation, handouts, and posttest. Participants were asked 
to provide an email address if they were willing to participate in a six-week follow-up 
posttest. Provision of the email address was optional.  
Treatment of Data/Outcomes/Evaluation Plan 
 Education regarding neonatal abstinence syndrome and nonpharmacological 
interventions for NAS infants was provided to healthcare professionals caring for 
newborns in a hospital setting December 2020 through January 2021. Pretest and posttest 
surveys were utilized to assess individual knowledge, confidence, and current practice. 
The pretest and posttests included questions over sociodemographic data, knowledge, 
confidence level, utilization of nonpharmacological interventions, and barriers to care. 
The pretest and posttests were distributed to participants immediately prior to the 
education, immediately following the education, and six weeks after the education.   
Evaluation Measures Linked to Objectives  
 The purpose of this study was to evaluate prevailing attitudes, practices, 
knowledge, and confidence of healthcare professionals regarding current care of infants 
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diagnosed with NAS. Pretest and posttest surveys were administered via the third-party 
web-based software Qualtrics. The results of this study were analyzed to determine if 
knowledge of nonpharmacological interventions increased among healthcare 
professionals and if there was an increase in the intent to utilize nonpharmacological 
interventions after the educational presentation was presented.  
 Methods of Analysis.  The data from the surveys was analyzed using descriptive 
and t-test statistics to determine if knowledge and confidence in the utilization of 
nonpharmacological interventions for the management of NAS increased after healthcare 
professionals caring for newborns in a hospital setting completed the education. 
Descriptive statistics included gender, age, NAS knowledge, and confidence. A paired t-
test for summative average was utilized via SPSS to compare average scores of survey 
responses pre and post NAS education. The pretest and posttests maintained 
confidentiality and were provided through Qualtrics. 
Plan for Sustainability 
 Sustainability of this project was key in increasing healthcare providers’ 
knowledge and confidence in caring for infants diagnosed with NAS. This education will 
help healthcare providers provide higher quality of care and stay up to date on current 
clinical practice guidelines, potentially reducing pharmacological interventions when 
caring for an infant with NAS. The potential for reduced pharmacological interventions 
can lead to decreased length of hospitalization stays as well as decreased healthcare costs.  
 Sustainability will be improved with timing. Strategies for timing include 
education delivery during provider orientation as well as re-education on an annual basis. 
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Early education in conjunction with annual education will keep healthcare provider 
knowledge and confidence high when providing care to an infant diagnosed with NAS.  
Summary 
 The increasing incidence of neonatal abstinence syndrome should be of great 
concern to healthcare providers, especially for healthcare professionals caring for 
newborns that are diagnosed with NAS. Healthcare professionals are important advocates 
to help improve infant outcomes and reduce not only length of stay but also reduce 
healthcare costs when caring for infants diagnosed with NAS by utilizing 
nonpharmacological interventions. Studies have shown that the utilization of 
nonpharmacological interventions in the management of NAS improves overall infant 
outcomes. The goal of this project was to increase healthcare professionals’ knowledge, 
confidence, and intent of utilizing nonpharmacological interventions in the treatment of 
NAS by providing education. Through education, healthcare professionals caring for 
newborns in a hospital setting will be better equipped and prepared to provide care to 
infants diagnosed with NAS, which will ultimately improve the quality of patient care 













Evaluation of Results 
 
 
  The purpose of this Doctor of Nursing Practice (DNP) scholarly project was to 
educate healthcare professionals caring for newborns diagnosed with neonatal abstinence 
syndrome (NAS) on nonpharmacological interventions. A pretest was given to healthcare 
professionals to identify current knowledge, confidence, and utilization of 
nonpharmacological interventions when caring for newborns diagnosed with NAS. 
Following the pretest, the researcher provided an educational offering in the form of a 
voice-recorded PowerPoint presentation through the third-party software Qualtrics. The 
educational offering introduced and explained neonatal abstinence syndrome, neonatal 
abstinence syndrome signs and symptoms, medications and drugs that can lead to 
neonatal abstinence syndrome, and nonpharmacological interventions that can be utilized 
when treating an infant with neonatal abstinence syndrome. After viewing the educational 
offering, healthcare professionals completed a posttest to determine if knowledge and 
confidence of neonatal abstinence syndrome and the utilization of nonpharmacological 
interventions in the treatment of neonatal abstinence syndrome increased after receiving 
education on the topic. Healthcare providers were then given the option to participate in a 
six-week follow-up posttest to determine if knowledge and confidence levels remained 
increased after the educational offering.   
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Description of Population 
 A convenience sampling of healthcare professionals, which included certified 
nurse aids (CNAs), registered nurses (RNs), lactation consultants (LCs), social workers, 
physician’s assistants (PAs), nurse practitioners (NPs), and physicians (MD or DO) were 
included in this study. Participants were recruited by contacting colleagues known to 
work as healthcare professionals caring for newborns in a hospital setting and asking 
them to participate. These colleagues were then asked to share the educational video and 
pre/posttest link with other healthcare professionals within their personal network, 
resulting in a snowball technique. Email, telephone contact, personal contact, and social 
media platforms were utilized to recruit participants. Inclusion criteria required 
participants to be healthcare professionals caring for newborns in a hospital setting, at 
least 18 years of age, and who utilized English as their primary language. Demographic 
data was divided into age, gender, profession, and length of time caring for newborns in a 
professional setting.  
 After pretest and posttest completion, the data was aggregated to form a total 
sample population of forty-seven participants. The pretest and posttest took place in the 
months of December 2020 and January 2021 via Qualtrics. Prior to viewing the 
educational presentation, participants completed a pretest assessing demographics, 
knowledge, and confidence levels. Immediately following the educational presentation, 
participants were given a posttest, which had identical questions as the pretest excluding 
demographic data. The posttest also gave participants the option to provide their email if 
they were willing to participate in a six-week posttest follow-up. Of the forty-seven 
participants only thirty participants completed the full pretest, educational presentation, 
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and posttest. Of the thirty participants that completed the full education, eight participants 
chose to participate in the six-week posttest follow-up.  
 Six weeks after education, participants were sent an email with the posttest 
education follow-up, which was identical to the posttest that immediately followed the 
educational offering. In total, eight six-week follow-up posttests were emailed and five 
responses were received. For accurate data comparison, the remainder of the data 
analyzed only compares results of participants who completed both pretest and posttest. 
The six-week follow-up posttest results were disregarded due to the small sample size. 
 The thirty total participants of this study all (100%) identified with the female 
gender and thirty (100%) selected nurse as their primary role. Of the thirty participants, 
one (3.33%) was between the ages of eighteen and twenty-one, fourteen (46.67%) were 
between the ages of twenty-one and thirty, six (20%) were between the ages of thirty-one 
and forty, six (20%) were between the ages of forty-one and fifty, one (3.33%) was 
between the ages of fifty-one and sixty, and two (6.67%) were sixty-one years old or 










Participant Age  
 
 The participants’ years of practice caring for newborns in a hospital setting 
varied. Among the participants, the majority had practiced greater than 10 years 
(36.67%). Other categories based on years of experience included participants who have 
been practicing for 6-10 years (26.67%), practicing for 1-5 years (33.33%), and 








Participant Years of Practice Caring for Newborns 
 
Analysis of Project Questions 
 This study utilized a pretest, educational presentation, and posttest with the option 
to participate in a six-week follow-up posttest to evaluate whether the educational 
presentation increased healthcare professionals’ knowledge of and confidence in utilizing 
nonpharmacological interventions when caring for an infant diagnosed with NAS. Data 
from the pretest was compared to the data from the posttest to determine if knowledge 
and confidence changed. There were four project questions addressed in this project. 
Each project question will be reviewed individually to ensure it is answered. 
 Project Question One. Prior to an educational offering, how frequently are 
healthcare professionals caring for newborns in the hospital setting completing a 
Finnegan Score on newborns born to women who tested positive for substances known to 
cause NAS? 
  First, participants were asked to identify how frequently they care for infants 
diagnosed with or showing signs and symptoms of NAS. Participants could indicate that 
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they care for infants diagnosed with NAS or showing signs/symptoms of NAS less than 
once a month, one to two times a month, three to five times a month, more than five 
times a month, or that they have never cared for an infant diagnosed with or displaying 
signs/symptoms of NAS. Of the thirty pretest participants, 43.33% (n=13) responded that 
they care for infants diagnosed with or showing signs/symptoms of NAS one to two times 
per month. Additionally, 33.33% (n=10) selected less than once a month, 20% (n=6) 
selected three to five times per month, 2.86% (n=1) selected they had never cared for an 
infant diagnosed with or displaying signs/symptoms of NAS, and no participants selected 
more than five times per month. (Table 1). 
Table 1  
Participant Frequency of Caring for NAS Diagnosed Infants 




Less than 1 time per month 10 33.33 
1-2 times per month 13 43.33 
3-5 times per month 6 20.00 
Greater than 5 times per month 0 0 
Never 1 3.33 
Total 30 100.00 
 
 Second, participants were asked how frequently the Finnegan Neonatal 
Abstinence Syndrome Scoring System Tool (FNAST) was being utilized when caring for 
an infant exposed to substance abuse in utero. Participants could indicate the utilization 
of the FNAST was occurring every two hours, every three hours, every four hours, every 
six hours, every eight hours, every twelve hours, as needed, or that their facility utilizes a 
different scoring tool with instructions to specify which tool. Of the thirty pretest 
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participants, 13.33% (n=4) indicated they score every two hours, 30% (n=9) indicated 
that they score every three hours, 20% (n=6) indicated that they score every four hours, 
16.67% (n=5) indicated they score as needed, and 20% (n=6) indicated their facility 
utilizes a different scoring tool (Table 2). The participants that indicated their facility 
utilizes a different scoring tool stated they utilize the Eat, Sleep, Console Method. 
Table 2 
Frequency of Utilization of Finnegan Neonatal Abstinence Scoring Tool 




Every 2 Hours 4 13.33 
Every 3 Hours 9 30.00 
Every 4 Hours 6 20.00 
Every 6 Hours 0 0 
Every 8 Hours 0 0 
Every 12 Hours 0 0 
As Needed 5 16.67 
Use a Different Scoring Tool 6 20.00 
Total 30 100.00 
 
 Project Question Two. Prior to an educational offering on the 
nonpharmacological management of NAS, which interventions are healthcare 
professionals caring for newborns in the hospital setting implementing?  
 Study participants were asked to identify nonpharmacological interventions they 
currently implement when caring for infants diagnosed with or displaying 
signs/symptoms of NAS. Participants answered the question via an open-ended text entry 
submission. Participant responses were reported prior to the educational presentation 
offering. Participants responded with several nonpharmacological interventions which 
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included rooming-in, consoling, quiet environments, dim lighting, low stimulation, skin 
to skin, frequent feeds, long rest periods, low noise, tight swaddling, containment, 
rocking, offering pacifiers, utilizing an infant swing, music therapy, utilizing sucrose, 
utilizing sensitive formula, clustered care, tummy time, patting, repositioning, and family 
involvement.  
 Project Question Three. Will implementation of nonpharmacological 
intervention education improve the knowledge of healthcare professionals caring for 
infants diagnosed with NAS in the hospital setting? 
 The correlation between neonatal abstinence syndrome education pretest and 
posttest was answered using data collected on pretest questions nine through eleven and 
posttest questions one through three. The participants were provided a five-point Likert 
rating scale presenting a statement with a one being very poor and five being very good. 
The questions were identical for both pretest and posttest. Participants were asked to rate 
current knowledge of neonatal abstinence syndrome, Finnegan Neonatal Abstinence 
Syndrome Scoring System Tool, and nonpharmacological interventions utilized for 
neonatal abstinence treatment. The responses to each of the five knowledge areas from 
the pretest are in Table 3 and those from the posttest are in Table 4. An overall 
summative average of participant perception of knowledge pre and post education was 







Pretest Average of Responses to Individual Knowledge Items 
Topic Mean Std. 
Deviation 
 






Finnegan Neonatal Abstinence Scoring System Tool 
 
3.67 0.82 
Nonpharmacological Interventions for the Treatment 
of NAS 
3.77 0.85 
Note. For observed means, 1=very poor; 2=poor; 3=fair; 4=good; 5=very good.  
Table 4 
Posttest Average of Response to Individual Knowledge Items 
Topic Mean Std. 
Deviation 
 










Nonpharmacological Interventions for the Treatment 
of NAS 
4.47 0.88 
Note. For observed means, 1=very poor; 2=poor; 3=fair; 4=good; 5=very good. 
 Using a five-point Likert scale from very poor to very good, participants’ 
responses to each individual item were analyzed. Responses were evaluated by the 
following scores: Very Poor (0-1.49), Poor (1.5-2.49), Fair (2.5-3.49), Good (3.5-4.49), 
and Very Good (4.5-5). All the mean individual responses for each item on the pretest 
and posttest fell between 3.5 and 4.49 or having “good” perception of knowledge both 
before and after the presentation. However, there was an increase in the respondents’ 




Summative Average of Knowledge Items 
 Mean N Std. 
Deviation 
 








Post-Summative Average of Knowledge 4.31 30 0.85 
Note. For observed means, 1=very poor; 2=poor; 3=fair; 4=good; 5=very good. 
 The pre-summative mean (3.72) indicates that participants had a “good” (3.5- 
4.49) perception of knowledge of individual items prior to the educational presentation. 
The post-summative mean (4.31) indicates that participants had an increase of points 
(0.59) indicating a “good” (3.5- 4.49) perception of knowledge after the educational 
presentation. 
Table 6 
Paired Sample Statistics for Knowledge Items  
 























Finnegan Neonatal Abstinence 

























 Paired Samples t-tests were calculated to see if there were statistical differences 
between the pre and post measures of participant perceived knowledge after the 
educational presentation. There was statistical difference between the pre and post 
measure for participant knowledge level for each knowledge item, neonatal abstinence 
syndrome overall ( t= 3.844, p < .001), Finnegan Neonatal Abstinence Syndrome Scoring 
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Tool ( t= 3.294, p = .003), and nonpharmacological interventions for the treatment of 
NAS ( t= 3.339, p = .002).  
 Project Question Four. Will implementation of nonpharmacological intervention 
education improve the confidence of healthcare professionals caring for infants diagnosed 
with NAS in the hospital setting? 
 The confidence level of healthcare professionals was assessed with the pretest 
questions twelve through fifteen and posttest questions four through seven. Participants 
were asked to rate their current confidence in caring for an infant diagnosed with NAS, 
recognizing signs/symptoms of NAS, utilizing the Finnegan NAS scoring system tool, 
and implementing nonpharmacological interventions. The participants were provided a 
three-point Likert scale to rate their confidence in four areas of care. Responses were 
evaluated by the following scores: Not Confident (0-1.00), Somewhat Confident (1.01-
2.00), and Completely Confident (2.01-3). On both the pretest (Table 7) and posttest 
(Table 8), all the mean individual responses fell between 2.01 and 3.00 or Completely 
Confident. An overall summative average of participant perception of confidence pre and 











Pretest Average of Responses to Individual Confidence Items 
Topic Mean Std. 
Deviation 
 






Recognizing signs/symptoms of NAS 
 
2.47 0.56 




Interventions when Caring for NAS Diagnosed 
Infant 
2.23 0.56 




Posttest Average of Responses to Individual Confidence Items 
Topic Mean Std. 
Deviation 
 






Recognizing signs/symptoms of NAS 
 
2.73 0.44 




Interventions when Caring for NAS Diagnosed 
Infant 
2.77 0.42 








Summative Average of Confidence Items 
 Mean N Std. 
Deviation 
 








Post-Summative Average of 
Confidence 
2.65 30 0.46 
Note. For observed means, 1=Not Confident; 2=Somewhat Confident; 3=Completely 
Confident. 
 
 The pre-summative mean (2.28) indicates participants were “completely 
confident” (2.01- 3) prior to the educational presentation. The post-summative mean 
(2.65) shows participants had an increase of points (0.37), indicating that participants 
remained “completely confident” (2.01- 3) after the educational presentation.  
Table 10 
































































 Paired Samples t-tests were calculated to determine if there were statistical 
differences between the pre and post measures of participant perceived confidence after 
the educational presentation. There was statistical difference between the pre and post 
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measure for participant confidence for each item, caring for an infant diagnosed with 
NAS (t= 5.037, p < .001), recognizing signs/symptoms of NAS ( t= 2.804, p = .009), 
utilizing the Finnegan Scoring System Tool (t= 2.249, p = .032), and implementing 
nonpharmacological interventions (t= 5.113, p < .001). 
Additional Results 
 In the pretest, participants were asked to identify the biggest challenge when 
caring for an infant diagnosed with or displaying signs/symptoms of NAS. The responses 
included having to care for other couplets or infants/not having enough time to 
adequately care for all patients, parent compliance with plan of care, appropriately 
managing signs and symptoms the infant is displaying, parent involvement, inconsistent 
care among the care team, being nonjudgmental towards parents, inconsistent scoring 
between nurses, determining level of severity, early recognition of signs/symptoms, 
parent and healthcare professional education.  
 In the posttest, participants were asked to identify any new knowledge they had 
gained from the educational presentation. The responses included learning new 
information on signs/symptoms, medications, and nonpharmacological interventions, 
frequency of Finnegan scoring tool, and healthcare costs due to neonatal abstinence 
syndrome. The education also included bedside guides that could be utilized when caring 
for infants diagnosed with NAS. Participant comments stated that the bedside guides 
would be very useful for education and utilization when needed.  
Summary 
 Data analysis was completed using IBM SPSS Statistics. Descriptive analysis was 
utilized for quantitative and qualitative data interpretation. Prior to education, results of 
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the pretest indicated that healthcare professionals would benefit from receiving further 
education about neonatal abstinence syndrome and nonpharmacological interventions 
when treating infants diagnosed with NAS. After the educational offering, participants 
indicated their knowledge and confidence in caring for newborns with NAS and utilizing 
nonpharmacological interventions as a treatment method had increased.  
 The purpose of this project was to increase the education provided to healthcare 
professionals regarding neonatal abstinence syndrome and the nonpharmacological 
interventions that should be utilized when caring for infants diagnosed with NAS. 
Findings from this study indicate the need for increased neonatal abstinence syndrome 
and nonpharmacological intervention education to healthcare professionals caring for 















 The purpose of this project was to increase the education provided to healthcare 
professionals regarding neonatal abstinence syndrome (NAS) and the 
nonpharmacological interventions that should be utilized when caring for infants 
diagnosed with NAS. The study obtained data from healthcare professionals caring for 
newborns in the hospital setting by utilization of a pretest and an identical posttest 
without demographic questions. The pretest measured baseline participant knowledge and 
confidence of neonatal abstinence syndrome and nonpharmacological interventions prior 
to education being provided. The posttest measured participant knowledge and 
confidence after the educational presentation. An identical six-week follow-up posttest 
was optional for study participants; however, from the thirty study participants, only eight 
participants indicated they would partake in the six-week follow up posttest, and only 
five participants completed the six-week follow-up posttest. Therefore, the six-week 
follow-up posttest results were disregarded.  
Relationship of Outcomes to Research  
 Four research questions were examined for this project. Each question was 
answered thoroughly and completely. The following research questions were examined.  
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• Prior to an educational offering, how frequently are healthcare 
professionals caring for newborns in the hospital setting completing a 
Finnegan Score on newborns born to women who tested positive for 
substances known to cause NAS? 
• Prior to an educational offering on the nonpharmacological management 
of NAS, which interventions are healthcare professionals caring for 
newborns in the hospital setting implementing? 
• Will implementation of nonpharmacological intervention education 
improve the knowledge of healthcare professionals caring for infants 
diagnosed with NAS in the hospital setting? 
• Will implementation of nonpharmacological intervention education 
improve the confidence of healthcare professionals caring for infants 
diagnosed with NAS in the hospital setting? 
 The first question was examined by descriptive statistics percentages and 
frequencies. Participants were asked to identify how often the participant cares for an 
infant diagnosed with or displaying signs or symptoms of neonatal abstinence syndrome. 
The participants were then asked to identify how frequently the Finnegan Neonatal 
Abstinence Scoring System Tool is utilized when caring for an infant diagnosed with or 
displaying signs or symptoms of neonatal abstinence syndrome. The participants had a 
selection choice of every two hours, every three hours, every four hours, every six hours, 
every eight hours, every twelve hours, as needed, or that a different scoring tool is 
utilized. According to Cook & Fantasia (2019), “Finnegan scoring is started within 24 
hours of birth and serial assessments are completed every 3 to 4 hours when the newborn 
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is awake and fed. Neonates who do not require pharmacologic intervention should have 
scoring completed for 4 consecutive days [and] neonates who require medication to treat 
withdrawal symptoms are scored throughout treatment and for 48 to 72 hours after 
medication is ceased” (p. 359). Participants who responded that a different scoring tool 
was utilized were asked to identify the scoring tool. Of the participants (n=6) who 
selected the option of utilization of a different scoring tool, all participants (n=6, 100%) 
responded that the Eat, Sleep, Console (ESC) method is utilized. According to a study 
conducted by Grossman, Lipshaw, Osborn, and Berkwitt (2018), “infants managed by 
using the ESC approach were treated with morphine significantly less frequently than 
they would have been by using the [Finnegan Scoring] approach. The ESC approach is an 
effective method for the management of infants with NAS that limits pharmacologic 
treatment and may lead to substantial reductions in length of stay.” Categorical data was 
applied to find the frequency and percentages of each measure.  
 The second research question was examined by text analysis. Participants were 
asked the open-ended question “what nonpharmacological interventions do you 
implement when caring for an infant diagnosed with or displaying signs/symptoms of 
NAS?” Participant responses were varied and some responses had similar 
nonpharmacological interventions identified. Responses were examined and listed to gain 
further insight into participants’ current practices. Examples of nonpharmacological 
supportive care measures include gentle handling, on demand feedings, swaddling, dim 
light, low noise, frequent feedings, utilizing high calorie formulas, holding, cuddling, 
manual rocking, aromatherapy, massage therapy, skin-to-skin contact, pacifier use to 
promote “self-soothing”, caregiver rooming-in, breastfeeding, and increasing 
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parent/caregiver infant care (Allen et al., 2018, p. 1750; Artigas, 2014, p. 512; Cook & 
Fantasia, 2019, p. 360; Jansson, 2020, p. 10-13; Kocherlakota, 2014, p. e553; MacVicar 
& Kelly, 2019, p. 434-435). 
 The third research question was answered by comparing pretest and posttest 
surveys. Participants were asked to rate current knowledge of neonatal abstinence 
syndrome, Finnegan Neonatal Abstinence Syndrome Scoring Tool, and 
nonpharmacological interventions for neonatal abstinence on a five-point Likert-type 
scale, “very poor,” “poor,” “fair,” “good,” or “very good.” Each category was coded 
using numerical data 1-5 starting at number one (very poor) to number five (very good).  
 The summative mean of the data collected for knowledge revealed an increase in 
participant response by 0.59 points. The standard deviation increased when comparing 
the pretest (0.81) and the posttest (0.85). These findings indicate that participants 
perceived more knowledge of individual items after the educational presentation. 
However, the standard deviation increase indicates greater variability on the posttest 
versus the pretest. In a previous study conducted by Lucas and Knobel (2012), 
knowledge of neonatal abstinence syndrome and the Finnegan Neonatal Abstinence 
Syndrome Scoring Tool was increased when clinical practice guidelines and education 
were introduced to neonatal intensive care unit (NICU) nurses working in a level three 
NICU. 
 The fourth research question was answered by comparing pretest and posttest 
surveys. Participants were asked to rate current confidence of caring for an infant 
diagnosed with neonatal abstinence syndrome, recognizing signs/symptoms of neonatal 
abstinence syndrome, utilizing the Finnegan Neonatal Abstinence Syndrome Scoring 
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Tool, and implementing nonpharmacological interventions when caring for an infant 
diagnosed with neonatal abstinence syndrome. Participants were asked to rate confidence 
on a three-point Likert-type scale, “not confident,” “somewhat confident,” and 
“completely confident.” Each category was coded using numerical data 1-3 starting at 
number one (not confident) to number five (extremely confident).  
 The summative mean of the data collected for confidence revealed an increase in 
participant response by 0.37 points. The standard deviation decreased when comparing 
the pretest (0.61) and the posttest (0.46). These findings indicate participants perceived 
greater confidence of individual items after the educational presentation. The standard 
deviation was low, indicating less variability on the posttest compared to the pretest.  
Observations 
 General observations noted during the project include poor completion rates. 
Participants were recruited via convenience and snowball sampling via social media 
platforms. The study had a total of forty-seven participants; however, only thirty 
participants completed the full study. The study also had a six-week posttest option in 
which only eight of the thirty participants indicated interest. Of the eight participants that 
indicated interest in the six-week follow-up posttest, five participants responded.  
 The survey indicated increased knowledge and confidence in all measures. The 
measure with the least increase on both knowledge and confidence involved “recognizing 
signs and symptoms of NAS” and “utilizing the Finnegan NAS scoring tool.” The 
measure with the greatest increase on both knowledge and confidence involved 
implementing and utilizing nonpharmacological interventions in the treatment of NAS. 
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This indicates all measures are being met, but curriculum involving signs and symptoms 
and scoring tools should be re-evaluated for future educational designs.  
Evaluation of Theoretical Framework 
 The data from this research supports Orlando’s Nursing Process Discipline 
Theory of focusing on the patient’s needs. Orlando’s theory provides a framework for 
identifying and addressing the immediate needs of the patient, resulting in positive 
outcomes. This theory “focuses on the interaction between the [healthcare professional] 
and patient, perception validation, and the use of the nursing process to produce positive 
outcomes or patient improvement” (Petiprin, 2016, para. 9). Participants from this study 
are seeking tools and resources to improve their knowledge and confidence when 
utilizing nonpharmacological interventions when caring for infants diagnosed with or 
displaying signs/symptoms of neonatal abstinence syndrome.  
Evaluation of Logic Model 
 The logic model of this study identified the goal of this project, which was to 
increase the knowledge of nonpharmacological interventions in the management of 
neonatal abstinence syndrome by utilization of an educational presentation. The goal was 
obtained by utilization of a pretest, educational presentation, and a posttest. The study 
results show that education is beneficial for increasing knowledge and confidence 
regarding neonatal abstinence syndrome and the utilization of nonpharmacological 
interventions when caring for infants diagnosed with or displaying signs/symptoms of 
neonatal abstinence syndrome.  
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Limitations 
 The method chosen for the research participants was a one group pretest-posttest 
design using descriptive statistics, mean, and standard deviation. One limitation in the 
study included poor participation resulting in a sample size of thirty participants. The 
project timeline of December 2020 through January 2021 may have contributed to the 
smaller sample size. A larger timeline would be beneficial for a larger sample size. 
Another limitation is the potential for participant bias due to the nature of the topic. There 
was no sampling bias because participants were recruited by use of a convenience and 
snowball sampling via social media platforms. A final limitation to the study is there is 
no universal protocol for education and treatment of neonatal abstinence syndrome. 
Therefore, education, knowledge, confidence, and tools vary significantly between 
healthcare facilities. This was a small study with a convenience sample size of thirty and 
therefore cannot be generalized. This study should be repeated with a larger sample 
population for more accurate results. 
Implications for Future Projects and Research  
 Evaluation of healthcare professionals’ knowledge and confidence regarding 
neonatal abstinence syndrome and the utilization of nonpharmacological interventions in 
the treatment of neonatal abstinence syndrome is a cost-effective method to obtain a 
baseline for educational needs regarding the topic. The prevalence of maternal substance 
abuse resulting in neonatal abstinence syndrome continues to increase at an alarming rate 
in the United States. Between the years 2004 and 2010, the incidence of newborns 
diagnosed with NAS increased fivefold, which has inevitably increased the number of 
newborns requiring longer hospitalization and specialized care (Chiang et al., 2019, p. 
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1193). Therefore, increased education for healthcare professionals regarding neonatal 
abstinence syndrome should be utilized to provide better understanding and care to 
infants diagnosed with NAS. This research could be replicated with additional 
educational programs.  
 To improve the design for this project, the author could focus the education on 
specific nursing units to better assess educational needs and improvement upon 
completion of the project. The author could also utilize follow-up surveys at varying 
intervals to assess for knowledge retention and utilization of education in practice.  
Implications for Practice, Health Policy, and Education 
 The results of this study indicate there is a need for increased education regarding 
neonatal abstinence syndrome and the utilization of nonpharmacological interventions in 
the management of neonatal abstinence syndrome. Study outcomes were positive with a 
posttest mean of (4.31) on knowledge and a posttest mean of (2.65) on confidence. These 
results indicate that education is beneficial for improving knowledge and confidence 
regarding neonatal abstinence syndrome and nonpharmacological interventions. 
Recommendations to nursing practice could include the incorporation of neonatal 
abstinence syndrome and nonpharmacological intervention education curricula on an 
annual basis for healthcare professionals who care for newborns in a hospital setting. 
Implementation of annual education could potentially increase overall knowledge and 
confidence resulting in improved patient outcomes.  
 The results of this study and future studies can be utilized for healthcare 
professionals to advocate for increased educational opportunities and funding regarding 
neonatal abstinence syndrome. Legislative involvement could make education 
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mandatory, provide better funding for educational opportunities, and provide continuity 
between nursing units throughout the United States who care for infants diagnosed with 
neonatal abstinence syndrome.  
Summary 
 The purpose of this project was to increase healthcare professionals’ confidence, 
knowledge of, and intent of utilizing nonpharmacological interventions in the treatment 
of NAS. Through education, healthcare professionals caring for newborns in a hospital 
setting will be better equipped and prepared to care for infants diagnosed with NAS, 
which will ultimately improve patient care and outcomes. Nonpharmacological 
interventions have been shown to reduce the length of hospitalizations, minimize 
medication therapy, improve infant outcomes, and ultimately reduce healthcare 
associated costs (Allen et al., 2018; Kocherlakota, 2014). 
 This project included a study utilizing a pretest, educational presentation, and a 
posttest. The pretest indicated the need for increased education regarding neonatal 
abstinence syndrome for healthcare professionals caring for infants in a hospital setting. 
After the educational presentation, the posttest results indicated an increase in knowledge 
and confidence levels of healthcare professionals regarding neonatal abstinence 
syndrome and the utilization of nonpharmacological interventions when caring for infants 
diagnosed with NAS. This study will hopefully encourage healthcare professionals to 
partake in further educational opportunities to help improve knowledge of and confidence 
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For the following items, please select the letter by the answer that best represents 
you (one per item).  
 









C. Prefer not to answer 
 
3. What is your current age? 
 
A. Younger than 21 years old 
B. 21-30 years old 
C. 31-40 years old 
D. 41-50 years old 
E. 51-60 years old 
F. 61+ years old 
 
4. What is your current role in caring for newborns?  
 
A. Nurse Assistant 
B. Nurse 
C. Lactation Consultant 
D. Advanced Practice Nurse 
E. Physician Assistant  
F. Physician  
 
5. How long have you worked as a healthcare professional caring for newborns? 
 
A. Less than 1 year 
B. 1-5 years 
C. 6-10 years 






6. How frequently do you care for infants diagnosed with or showing signs and 
symptoms of Neonatal Abstinence Syndrome? 
 
A. Less than 1 time a month 
B. 1-2 times a month  
C. 3-5 times a month 
D. More than 5 times a month 
E. I have never cared for an infant diagnosed with or showing symptoms 
of NAS 
 
7. How frequently do you utilize the Finnegan Neonatal Abstinence Syndrome 
Scoring System when caring for an infant exposed to substance abuse while in-
utero? 
   
A. Never 
B. Every 2 hours 
C. Every 3 hours 
D. Every 4 hours 
E. Every 6 hours 
F. Every 8 hours 
G. Every 12 hours 
H. As needed 
I. My facility uses a different scoring tool (Please Specify) 
____________ 
 
8. During the past year, have you participated in an educational program about 
NAS? 




















Neonatal Abstinence Syndrome Knowledge 
 
Using the scale below, please select the number that best represents your knowledge of 
NAS. 
 
Very Poor = 1         Poor = 2         Fair = 3       Good = 4       Very Good = 5  
 
How do you rate your current knowledge of:  
 
 
9. Neonatal Abstinence Syndrome      1      2      3      4      5 
 
10. Finnegan Neonatal Abstinence Syndrome Scoring System     1      2      3      4      5 
 




Using the scale below, please select the following number that best represents your 
confidence level.  
 
Not Confident = 1 Somewhat Confident = 2 Completely Confident = 3 
 
How do you rate your current confidence with: 
 
 
12. Caring for an infant diagnosed with NAS    1     2     3      
 
13. Recognizing signs/symptoms of NAS    1     2     3     
 
14. Utilizing the Finnegan NAS Scoring System    1     2     3      
 




16. What nonpharmacological interventions do you implement when caring for an 
infant diagnosed with or displaying signs/symptoms of NAS? (Please answer 
below) 
 
            
            




17. What do you find to be the biggest challenge when caring for an infant diagnosed 
with or displaying signs/symptoms of NAS? (Please answer below) 
 
 
             
            
            
  
 












Neonatal Abstinence Syndrome Knowledge 
 
Using the scale below, please select the number that best represents your knowledge of 
NAS. 
 
Very Poor = 1         Poor = 2         Fair = 3       Good = 4       Very Good = 5  
 
After viewing the educational offering, how do you rate your knowledge of:  
 
 
1. Neonatal Abstinence Syndrome      1      2      3      4      5 
 
2. Finnegan Neonatal Abstinence Syndrome Scoring System     1      2      3      4      5 
 




Using the scale below, please select the following number that best represents your 
confidence level.  
 
Not Confident = 1 Somewhat Confident = 2  Completely Confident = 3 
 
After viewing the educational offering, how do you rate your confidence with: 
 
 
4. Caring for an infant diagnosed with NAS    1     2     3      
 
5. Recognizing signs/symptoms of NAS    1     2     3      
 
6. Utilizing the Finnegan NAS Scoring System    1     2     3      
 











8. What new knowledge have you learned after viewing the educational offering? 
 
            
            
   
 
 







10. If you are willing to participate in a 6 week follow up survey, please provide your 









6 Week Posttest 
 
 
Neonatal Abstinence Syndrome Knowledge 
 
Using the scale below, please select the number that best represents your knowledge of 
NAS. 
 
Very Poor = 1         Poor = 2         Fair = 3       Good = 4       Very Good = 5  
 
How do you rate your current knowledge of:  
 
 
1. Neonatal Abstinence Syndrome                    1      2      3      4      5 
 
2. Finnegan Neonatal Abstinence Syndrome Scoring System     1      2      3      4      5 
 




Using the scale below, please select the following number that best represents your 
confidence level.  
 
Not Confident = 1  Somewhat Confident = 2  Completely Confident = 3 
 
How do you rate your current confidence with: 
 
 
4. Caring for an infant diagnosed with NAS    1     2     3      
 
5. Recognizing signs/symptoms of NAS    1     2     3      
 
6. Utilizing the Finnegan NAS Scoring System    1     2     3  
 









8. What nonpharmacological interventions do you implement when caring for an 
infant diagnosed with or displaying signs/symptoms of NAS? (Please answer 
below) 
 
            
            
   
 
 
9. What do you find to be the biggest challenge when caring for an infant diagnosed 
with or displaying signs/symptoms of NAS? (Please answer below) 
 
 
             
            
            
   
 
 
10. Has the educational guide for nonpharmacological interventions in the treatment 
of infants with NAS changed how you provide care for these infants? If yes please 





            
   
 












Neonatal Abstinence Syndrome Bedside Tools 
 






Heroin 24 hours- 2 days 8-10 days 
Methadone 2-3 days  30 days or more 
Buprenorphine (Subutex) 24 hours- 3 days  28 days or more 
Prescription Opioids 
(oxycodone/hydrocodone 
24 hours – 4 days 10- 30 days 
NON-OPIOIDS 
 
SSRIS (Celexa, Lexapro, Zoloft, 
Paxil, Prozac)  
24 hours- 2 days  2-6 days  
Tricyclic Antidepressants (Elavil, 
Sinequian, Vivactil, Pamelor, 
Anafranil, Surmontil, Amoxapine) 
24 hours – 2 days  2-6 days  
Methamphetamines  24 hours 7-10 days 
Inhalants/nicotine 24 hours – 2 days 2-7 days 





  Baby’s 
Behavior 
How You Can Help 
Prolonged 
Crying 
• Hold baby skin to skin or swaddled in light blanket close to parent’s 
body 
• Lower the lights and turn off loud noises 
• Use purposeful touch (stroking, or tickling can be irritating).  
• Hold baby swaddled in a “C” or fetal position with baby’s back to you 
facing outward at a blank wall. Gently sway from side to side.  
• Hum and gently rock from side to side. 
• Watch for prolonged crying, which may cause baby to vomit.  
Easily Upset or 
Bothered 
• Keep the room quiet and dim. Avoid loud music, TV/screen-time, 
texting, phone calls, and conversations.  
• Try not to touch or wake the baby. 
• Swaddle baby in a light blanket, but help him stay contained with hands 
close to his face.  
• Hold baby close to your body, and console him if he is upset.  
Sleeplessness • Limit visitors and keep the room quiet.  
• Soft, gentle music and rocking may help. 
• Keep diaper area clean and dry. Use diaper cream to prevent diaper rash.  
• Feed baby when he’s hungry (small/frequent meals may be needed). 
Difficult or Poor 
Feeding 
• Feed small amounts often. If breastmilk supply is low, supplement with 
formula to help infant feel satisfied.  
• Feed in a quiet, low-lit room with few distractions.  





• Offer a pacifier if baby has just eaten and still wants to suck 
• Keep baby’s hands clean. Do not use lotions or creams.  
• Keep baby swaddled and comforted  
• Offer a small meal 
Spitting up or 
Vomiting 
• Use a bulb syringe to clean out baby’s mouth 
• Change bedding and clothes to keep baby comfortable.  
• Burp baby often throughout feedings and offer rest breaks. 
• Offer smaller meals more often if large volumes cause vomiting 





• Keep baby’s mouth and nose clean. Note any spit-up or mucus. 
Stuffiness is often swelling/edema and cannot be suctioned. 
• Dress baby in light T-shirt or onesie and swaddle in a light blanket.  
• Feed baby slowly and offer rest breaks and burping with each feeding. 
• Always place baby on its back to sleep 
• If baby is awake hold him upright, fully supporting his head.  
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and Stress Cues 
Infant Displays: 
 
 
Effective Calming 
Interventions: 
 
 
Primary Nursing 
Staff: 
 
 
Social Work 
Support/Plans: 
 
 
 
